Skip to main content
. 2011 Aug 18;5(3):363–366. doi: 10.5009/gnl.2011.5.3.363

Fig. 1.

Fig. 1

Diagram of the study population. Of 341 adult living donor liver transplantations, 26 HBcAb-positive grafts were transplanted into HBsAg-negative recipients. Without anti-HBV prophylaxis, 2 of the 26 (7.7%) recipients of positive grafts developed de novo HBV infection.

LDLT, living donor liver transplantation; HBsAg, hepatitis B surface antigen; HBcAb, hepatitis B core antibody; HBsAb, hepatitis B surface antibody; HBV, Hepatitis B virus.